Clinical Research
Currently Enrolling Studies
We participate in cutting-edge research that may give you access to new treatments — at no cost to you. See what’s open today.
Open Studies — April 2026
Artiva-05
Ra · Sjd · Sle · Ssc
Investigating a novel therapeutic approach across four autoimmune conditions: Rheumatoid Arthritis, Sjögren’s Disease, Lupus, and Systemic Sclerosis.
Lilly GZPT
Knee Osteoarthritis
A Lilly-sponsored study evaluating a new treatment option for patients living with knee osteoarthritis and chronic joint pain.
Lilly RHDE
PSA · Tirzepatide
A Lilly study for Psoriatic Arthritis patients evaluating Tirzepatide (Talz/Tirzepatide combination), an exciting dual-mechanism investigational therapy.
MK-013
Axial Spondyloarthritis
Examining an investigational treatment for Axial Spondyloarthritis (AxSpA), a form of inflammatory arthritis primarily affecting the spine and sacroiliac joints.
MK-014
Rheumatoid Arthritis
Evaluating a new investigational compound for Rheumatoid Arthritis patients seeking additional or alternative treatment options.
TAK-3002
Psoriatic Arthritis
A Takeda-sponsored trial for patients with Psoriatic Arthritis, exploring a targeted therapy to reduce joint inflammation and improve quality of life.
Think you may qualify?
Call our office and we’ll help determine if a study is the right fit for you.
Please note: Participation in research studies is always voluntary. Study eligibility varies based on individual health history and other criteria. Our team will discuss all details, risks, and benefits with you before any enrollment. Studies listed are subject to change as enrollment fills or protocols are updated.
